Center for Scientific Review; Notice of Closed Meetings, 32109-32110 [06-5067]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 106 / Friday, June 2, 2006 / Notices
8 a.m. to June 27, 2006, 11 a.m., Double
Tree Rockville, 1750 Rockville Pike,
Rockville, MD 20852, which was
published in the Federal Register on
May 16, 2006, 71 FR 28365–28367.
The meeting will be held at the
Crowne Plaza Hotel, 8777 Georgia
Avenue, Silver Spring, MD 20910. The
meeting dates and time remain the
same. The meeting is closed to the
public.
Dated: May 25, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5065 Filed 6–1–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Neural Basis of
Psychopathology, Addictions and Sleep
Disorders Study Section, June 21, 2006,
6 p.m. to June 23, 2006, 5 p.m., Embassy
Suites Hotel, 4300 Military Road,
Washington, DC 20015, which was
published in the Federal Register on
May 11, 2006, 71 FR 27505–27507.
The meeting will be held June 22,
2006, 8 a.m. to June 23, 2006, 5 p.m.
The meeting location remains the same.
The meeting is closed to the public.
Dated: May 25, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5066 Filed 6–1–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jlentini on PROD1PC65 with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
VerDate Aug<31>2005
18:05 Jun 01, 2006
Jkt 208001
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Oral
Microbiology and Dental Material Sciences:
A Member Conflict Panel.
Date: June 16, 2006.
Time: 12:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Tamizchelvi Thyagarajan,
PhD, Scientific Review Administrator, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4016K,
MSC 7814, Bethesda, MD 20892. 301–451–
1327. tthyagar@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Brain
Disorders and Clinical Neurosciences
Member Conflicts.
Date: June 19–20, 2006.
Time: 8:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Omni Shoreham Hotel, 2500 Calvert
St., NW., (at Connecticut Ave.), Palladian
Ballroom, Washington, DC 20037.
Contact Person: Suzan Nadi, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892. 301–435–
1259. nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Retinopathy
studies.
Date: June 22–23, 2006.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Raya Mandler, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217,
MSC 7840, Bethesda, MD 20892. (301) 402–
8228. raym@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group, Cognition and Perception Study
Section.
Date: June 22–23, 2006.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Rouge, 1315 16th Street, NW.,
Washington, DC 20036.
Contact Person: Cheri Wiggs, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3180,
MSC 7848, Bethesda, MD 20892. (301) 435–
1261. wiggsc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Risk,
Prevention and Intervention for Addictions.
Date: June 22–23, 2006.
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
32109
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Gayle M. Boyd, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3028–D,
MSC 7759, Bethesda, MD 20892. 301–451–
9956. gboyd@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Signaling in
Cancer.
Date: June 27, 2006.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Chhanda L. Ganguly, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7802, Bethesda, MD 20892. (301) 435–
1739. gangulyc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Dissemination and Implementation Research
in Health.
Date: June 28, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Steven H. Krosnick, MD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3028A,
MSC 7770, Bethesda, MD 20892. (301) 435–
1712. krosnics@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, In Vitro
Drug Toxicity.
Date: June 28, 2006.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Maqsood A. Wani, PhD,
DVM, Scientific Review Administrator,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 2114, MSC 7814, Bethesda, MD 20892.
301–435–2270. wanimaqs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Meiosis.
Date: June 28, 2006.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Noni Byrnes, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130
MSC 7840, Bethesda, MD 20892. (301) 435–
1023. byrnesn@csr.nih.gov.
E:\FR\FM\02JNN1.SGM
02JNN1
32110
Federal Register / Vol. 71, No. 106 / Friday, June 2, 2006 / Notices
jlentini on PROD1PC65 with NOTICES
Name of Committee: Immunology
Integrated Review Group, Vaccines Against
Microbial Diseases.
Date: June 29–30, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jian Wang, MD, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892. (301) 435–
2778. wangjia@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Biophysical
and Biochemical Sciences Fellowship Panel.
Date: June 29–30, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Churchill Hotel, 1914 Connecticut
Avenue, NW., Washington, DC 20009.
Contact Person: James W. Mack, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892. (301) 435–1747. mackj2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict-Behavioral Pharmacology.
Date: June 29, 2006.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Maribeth Champoux, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3146,
MSC 7759, Bethesda, MD 20892. (301) 594–
3163. champoum@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Technology
Development.
Date: June 29–30, 2006.
Time: 6 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavillon, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Sally Ann Amero, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7849, Bethesda, MD 20892. (301) 435–
1159. ameros@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396. 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 25, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5067 Filed 6–1–06; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
18:05 Jun 01, 2006
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Human Monoclonal
Antibodies, Their Fragments and
Derivatives as Biotherapeutics for the
Treatment of HIV Infections
AGENCY: National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), that the National
Institutes of Health (NIH), Department
of Health and Human Services (HHS), is
contemplating the grant of an exclusive
license to practice the inventions
embodied in: U.S. Provisional Patent
Application S/N 60/378,408, filed May
6, 2002 (E–144–2002/0–US–01), PCT
Application, PCT/US03/14292, filed
May 6, 2003, (E–144–2002/0–PCT–02),
converted into 03736557.4 (E–144–
2002/0–EP–04) filed in Europe on
December 3, 2004, and 2003237187 (E–
144–2002/0–AU–05) filed in Australia
on November 3, 2004, 10/513,725 (E–
144–2002/0–US–03) filed in USA on
November 5, 2004, as well as 2,484,930
(E–144–2002/0–CA–06) filed in Canada
on November 5, 2004, entitled ‘‘Novel
broadly cross-reactive HIV neutralizing
human monoclonal antibodies selected
from Fab phage display libraries using
a novel strategy based on alternative
antigen panning,’’ Inventors: Dimiter S.
Dimitrov (NCI) and Mei-Yun Zhang
(SAIC), to Profectus Biosciences, Inc.,
having a place of business in Baltimore,
Maryland. The patent rights in these
inventions have been assigned to the
United States of America.
DATES: Only written comments and/or
application for a license, which are
received by the NIH Office of
Technology Transfer on or before
August 1, 2006 will be considered.
ADDRESSES: Requests for a copy of the
patent application, inquiries, comments
and other materials relating to the
contemplated license should be directed
to: Sally Hu, Ph.D., M.B.A., Office of
Technology Transfer, National Institutes
of Health, 6011 Executive Boulevard,
Suite 325, Rockville, MD 20852–3804;
E-mail: hus@od.nih.gov; Telephone:
(301) 435–5606; Facsimile: (301) 402–
0220.
SUPPLEMENTARY INFORMATION: The
subject invention (E–144–2002/0)
identifies four antibodies, designed
4B1–4, 4B1–10, 4H4, and 5H22 (M12,
M14, M16, and M18). These four
antibodies were isolated from a human
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
Fab phage display library using
alternating antigen panning (AAP). All
four antibodies bind to recombinant HIV
envelope glycoproteins (Env) gp12089.6,
gp120JR–FL and gp120IIIB with high
affinity. Moreover, 4B1–10 binding to gp
120 or gp 140 is significantly enhanced
in the presence of the receptor CD4.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless,
within 60 days from the date of this
published Notice, NIH receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR 404.7.
The field of use may be limited to the
development of human monoclonal
antibodies for use as a therapeutic or
preventative in HIV infection either
alone or in combination with other
compounds.
Properly filed competing applications
for a license filed in response to this
notice will be treated as objections to
the contemplated license. Comments
and objections submitted in response to
this notice will not be made available
for public inspection, and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: May 25, 2006.
David R. Sadowski,
Acting Director, Division of Technology
Development and Transfer, Office of
Technology Transfer, National Institutes of
Health.
[FR Doc. E6–8628 Filed 6–1–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
First-Generation Guidelines for NCISupported Biorepositories
AGENCY: National Institutes of Health
(NIH), National Cancer Institute (NCI),
HHS.
ACTION: Notice.
SUMMARY: The public comment period
for the First Generation Guidelines for
NCI-Supported Biorepositories (Federal
Register, Vol. 71, Number 82, Page
25814, April 28, 2006) will be extended
an additional 30 days beyond
publication of this notice.
DATES: Effective Date: July 3, 2006.
FOR FURTHER INFORMATION CONTACT:
Implementation assistance and inquiries
should be directed to senior staff of the
E:\FR\FM\02JNN1.SGM
02JNN1
]]>Agencies
[Federal Register Volume 71, Number 106 (Friday, June 2, 2006)]
[Notices]
[Pages 32109-32110]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5067]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Oral Microbiology and Dental Material Sciences: A Member
Conflict Panel.
Date: June 16, 2006.
Time: 12:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Tamizchelvi Thyagarajan, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4016K, MSC 7814, Bethesda, MD
20892. 301-451-1327. tthyagar@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Brain Disorders and Clinical Neurosciences Member Conflicts.
Date: June 19-20, 2006.
Time: 8:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Omni Shoreham Hotel, 2500 Calvert St., NW., (at
Connecticut Ave.), Palladian Ballroom, Washington, DC 20037.
Contact Person: Suzan Nadi, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD
20892. 301-435-1259. nadis@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Retinopathy studies.
Date: June 22-23, 2006.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC
20037.
Contact Person: Raya Mandler, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217, MSC 7840, Bethesda, MD
20892. (301) 402-8228. raym@csr.nih.gov.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group, Cognition and Perception Study Section.
Date: June 22-23, 2006.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Rouge, 1315 16th Street, NW., Washington, DC 20036.
Contact Person: Cheri Wiggs, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3180, MSC 7848, Bethesda, MD
20892. (301) 435-1261. wiggsc@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Risk, Prevention and Intervention for Addictions.
Date: June 22-23, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW.,
Washington, DC 20007.
Contact Person: Gayle M. Boyd, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3028-D, MSC 7759, Bethesda, MD
20892. 301-451-9956. gboyd@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Signaling in Cancer.
Date: June 27, 2006.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Chhanda L. Ganguly, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118, MSC 7802, Bethesda, MD
20892. (301) 435-1739. gangulyc@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Dissemination and Implementation Research in Health.
Date: June 28, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC
20037.
Contact Person: Steven H. Krosnick, MD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3028A, MSC 7770, Bethesda, MD
20892. (301) 435-1712. krosnics@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, In Vitro Drug Toxicity.
Date: June 28, 2006.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Maqsood A. Wani, PhD, DVM, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114, MSC 7814, Bethesda, MD
20892. 301-435-2270. wanimaqs@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Meiosis.
Date: June 28, 2006.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Noni Byrnes, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130 MSC 7840, Bethesda, MD
20892. (301) 435-1023. byrnesn@csr.nih.gov.
[[Page 32110]]
Name of Committee: Immunology Integrated Review Group, Vaccines
Against Microbial Diseases.
Date: June 29-30, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Jian Wang, MD, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD
20892. (301) 435-2778. wangjia@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Biophysical and Biochemical Sciences Fellowship Panel.
Date: June 29-30, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Churchill Hotel, 1914 Connecticut Avenue, NW.,
Washington, DC 20009.
Contact Person: James W. Mack, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892. (301) 435-1747.
mackj2@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict-Behavioral Pharmacology.
Date: June 29, 2006.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Maribeth Champoux, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3146, MSC 7759, Bethesda, MD
20892. (301) 594-3163. champoum@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Technology Development.
Date: June 29-30, 2006.
Time: 6 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavillon, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Sally Ann Amero, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190, MSC 7849, Bethesda, MD
20892. (301) 435-1159. ameros@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396. 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 25, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5067 Filed 6-1-06; 8:45 am]
BILLING CODE 4140-01-M
